Publicaciones (56) Publicaciones de JOSÉ ÁNGEL MORALES GARCÍA

2024

  1. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

2023

  1. C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease

    Cells, Vol. 12, Núm. 5

  3. Dissecting operant alcohol self-administration using saccharin-fading procedure

    Neuropsychopharmacology Reports, Vol. 43, Núm. 1, pp. 12-22

  4. Melatonin: A multitasking indoleamine to modulate hippocampal neurogenesis

    Neural Regeneration Research, Vol. 18, Núm. 3, pp. 503-505

  5. Neuroprotective properties of queen bee acid by autophagy induction

    Cell Biology and Toxicology, Vol. 39, Núm. 3, pp. 751-770

  6. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10

2022

  1. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies

    Addiction biology, Vol. 27, Núm. 6, pp. e13229

  2. Editorial: New Insights Into Adult Neurogenesis and Neurodegeneration: Challenges for Brain Repair

    Frontiers in Neuroscience

  3. Insights into the Pharmacokinetics and In Vitro Cell‐Based Studies of the Imidazoline I2 Receptor Ligand B06

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  4. Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy

    Cells, Vol. 11, Núm. 15

  5. Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades

    Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4727-4751

  6. Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission

    IJID Regions, Vol. 4, pp. 10-16

2021

  1. Ayahuasca as a Versatile Therapeutic Agent: From Molecules to Metacognition and Back

    Ayahuasca Healing and Science, pp. 1-19

  2. The immune system through the lens of alcohol intake and gut microbiota

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2020

  1. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease

    Aging, Vol. 12, Núm. 17, pp. 16690-16708

  2. N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo

    Translational Psychiatry, Vol. 10, Núm. 1

  3. Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease

    Molecular Neurobiology, Vol. 57, Núm. 2, pp. 806-822

  4. Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

    European Journal of Medicinal Chemistry, Vol. 190

2019

  1. New flavonoid–N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 712-727